Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor
NCT ID: NCT00861354
Last Updated: 2010-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2009-03-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Device-detected Paroxysmal Atrial Fibrillation
NCT02442505
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
NCT04198701
Study Watch AF Detection At Home
NCT04546763
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
NCT02232022
Clinical Performance of AFGen1
NCT06076798
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microlife blood pressure monitor with AF detection (Microlife AFIB MLU3MQ1)
Monitoring heart rhythm daily for 30 days using the blood pressure monitor and the ECG recorder.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hypertension
* diabetes mellitus
* congestive heart failure
* previous stroke
Exclusion Criteria
* impalantable defibrillator
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Microlife
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Microlife
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Wiesel, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joseph Wiesel, MD medical office
Flushing, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
tripps2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.